Drug Companies Set to Make Billions Off Swine Flu
Filed under Drug Companies, Relenza, Swine Flu Vaccine, Tamiflu |
Drug companies are set to make billions off the swine flu.
In addition to the money to be made from the vaccines that will be rushed to market without adequate safety trials this fall, GlaxoSmithKline, which manufactures Relenza, and Roche, which manufactures Tamiflu, are already raking in the money and will make billions more as orders for these two antivirals continue to come in from around the world.
Pharmaceutical companies that are making swine flu vaccines include Baxter International, Sanofi-Aventis SA, Novartis, and GlaxoSmithKline.
While you're browsing our articles, take a moment to enter your email below to receive free Swine Flu Blog updates via email. (We value your privacy and will never sell or give away your e-mail. You can unsubscribe at any time.)